UBS initiates coverage on MiniMed Group (NASDAQ: MMED) with a Buy rating and a price target of $25.00.

For an analyst ratings summary and ratings history on MiniMed Group click here. For more ratings news on MiniMed Group click here.

Shares of MiniMed Group closed at $17.64 yesterday.